Background Endoscopic sleeve gastroplasty (ESG) is an endolumenal, organ-sparing
therapy for obesity, with wide global adoption. We aimed to explore the efficacy and safety of …

Background Endoscopic sleeve gastroplasty (ESG) has emerged as a promising technique
in endoscopic bariatric and metabolic therapies (EBMTs). We aimed to perform a systematic …

Intragastric balloons (IGB) are the most widely used endoscopic bariatric and metabolic
therapies. We aimed to evaluate the efficacy of IGB in comparison with sham or lifestyle …

Importance Obesity is a disease with a large socioeconomic burden. Endoscopic sleeve
gastroplasty (ESG) is a minimally invasive endoscopic bariatric procedure with wide global …

Background We aimed to individually evaluate IGB and ESG procedures and compare the
efficacy, durability, and safety of these procedures. Methods Bibliographic databases were …

Background Primary obesity surgery endoluminal (POSE) utilizes an incision-less operating
platform system to create full-thickness plications in the gastric fundus and body (original …

Nonalcoholic fatty liver disease (NAFLD) affects at least 25% of the global adult population
and is one of the leading causes of cirrhosis and hepatocellular carcinoma (HCC) in western …

Background Endoscopic sleeve gastroplasty (ESG) is an effective treatment option for
obesity. However, data comparing its efficacy to bariatric surgery are scarce. We aimed to …

NAFLD and its inflammatory condition NASH, which is more likely to progress to fibrosis and
advanced liver disease, are the histologic manifestation of a heterogeneous disease closely …

Non-alcoholic fatty liver disease (NAFLD) is becoming a major cause of liver disease-related
morbidity, as well as mortality. Importantly, NAFLD is considered a mediator of systemic …